Table 3.
Study | Pedro score | Point estimates & variability | Between group comparison | Intention to treat | Adequate follow-up | Blind assessors | Blind therapists | Blind subjects | Baseline comparability | Concealed allocation | Random allocation | Eligibility criteria |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Shahraki et al. 69 | 4 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Seebacher et al. 70 | 7 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Seebacher et al. 71 | 6 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Conklyn et al. 41 | 5 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Baram and Miller 42 | 4 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |